These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 9179366

  • 1. Mistletoe extract-induced effects on immunocompetent cells: in vitro studies.
    Stein GM, Berg PA.
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S39-42. PubMed ID: 9179366
    [Abstract] [Full Text] [Related]

  • 2. Mistletoe (viscum album) lectins as cytokine inducers and immunoadjuvant in tumor therapy. A review.
    Bocci V.
    J Biol Regul Homeost Agents; 1993 Apr; 7(1):1-6. PubMed ID: 8346712
    [Abstract] [Full Text] [Related]

  • 3. Effect of a recombinant lectin, Viscum album agglutinin on the secretion of interleukin-12 in cultured human peripheral blood mononuclear cells and on NK-cell-mediated cytotoxicity of rat splenocytes in vitro and in vivo.
    Hajto T, Hostanska K, Weber K, Zinke H, Fischer J, Mengs U, Lentzen H, Saller R.
    Nat Immun; 1998 Apr; 16(1):34-46. PubMed ID: 9789123
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the effects of Viscum album lectin ML-1 and fresh plant extract (Isorel) on the cell growth in vitro and tumorigenicity of melanoma B16F10.
    Zarković N, Kalisnik T, Loncarić I, Borović S, Mang S, Kissel D, Konitzer M, Jurin M, Grainza S.
    Cancer Biother Radiopharm; 1998 Apr; 13(2):121-31. PubMed ID: 10850348
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Modulation of cytotoxicity and enhancement of cytokine release induced by Viscum album L. extracts or mistletoe lectins.
    Ribéreau-Gayon G, Jung ML, Frantz M, Anton R.
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S3-8. PubMed ID: 9179359
    [Abstract] [Full Text] [Related]

  • 7. Inability of galactoside-specific mistletoe lectin to inhibit N-methyl-N-nitrosourea-induced tumor development in the urinary bladder of rats and to mediate a local cellular immune response after long-term administration.
    Kunze E, Schulz H, Gabius HJ.
    J Cancer Res Clin Oncol; 1998 Apr; 124(2):73-87. PubMed ID: 9654190
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Non-lectin component in a fermented extract from Viscum album L. grown on pines induces proliferation of lymphocytes from healthy and allergic individuals in vitro.
    Stein G, Berg PA.
    Eur J Clin Pharmacol; 1994 Apr; 47(1):33-8. PubMed ID: 7988621
    [Abstract] [Full Text] [Related]

  • 10. Clinical relevance of immunoactive mistletoe lectin-I.
    Beuth J.
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S53-5. PubMed ID: 9179369
    [Abstract] [Full Text] [Related]

  • 11. Flow cytometric analyses of the specific activation of peripheral blood mononuclear cells from healthy donors after in vitro stimulation with a fermented mistletoe extract and mistletoe lectins.
    Stein GM, Berg PA.
    Eur J Cancer; 1998 Jun; 34(7):1105-10. PubMed ID: 9849462
    [Abstract] [Full Text] [Related]

  • 12. Release of cytokines by a fermented lectin-1 (ML-1) free mistletoe extract reflects differences in the reactivity of PBMC in healthy and allergic individuals and tumour patients.
    Stein GM, Meink H, Durst J, Berg PA.
    Eur J Clin Pharmacol; 1996 Jun; 51(3-4):247-52. PubMed ID: 9010693
    [Abstract] [Full Text] [Related]

  • 13. Characterization of cytotoxic proteins from mistletoe (Viscum album L.).
    Jung ML, Baudino S, Ribéreau-Gayon G, Beck JP.
    Cancer Lett; 1990 May 30; 51(2):103-8. PubMed ID: 2344587
    [Abstract] [Full Text] [Related]

  • 14. Differences in the apoptosis-inducing properties of Viscum album L. extracts.
    Büssing A, Suzart K, Schweizer K.
    Anticancer Drugs; 1997 Apr 30; 8 Suppl 1():S9-14. PubMed ID: 9179360
    [Abstract] [Full Text] [Related]

  • 15. Induction of anti-mistletoe lectin antibodies in relation to different mistletoe-extracts.
    Stein GM, Stettin A, Schultze J, Berg PA.
    Anticancer Drugs; 1997 Apr 30; 8 Suppl 1():S57-9. PubMed ID: 9179370
    [Abstract] [Full Text] [Related]

  • 16. Antiproliferative potential from aqueous Viscum album L. preparations and their main constituents in comparison with ricin and purothionin on human cancer cells.
    Felenda JE, Turek C, Stintzing FC.
    J Ethnopharmacol; 2019 May 23; 236():100-107. PubMed ID: 30840914
    [Abstract] [Full Text] [Related]

  • 17. [Mistletoe therapy from the pharmacologic perspective].
    Hajto T, Hostanska K, Saller R.
    Forsch Komplementarmed; 1999 Aug 23; 6(4):186-94. PubMed ID: 10529578
    [Abstract] [Full Text] [Related]

  • 18. Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoe lectins.
    Büssing A, Suzart K, Bergmann J, Pfüller U, Schietzel M, Schweizer K.
    Cancer Lett; 1996 Jan 19; 99(1):59-72. PubMed ID: 8564930
    [Abstract] [Full Text] [Related]

  • 19. Cellular and humoral adjuvant activity of lectins isolated from Korean mistletoe (Viscum album colaratum).
    Yoon TJ, Yoo YC, Kang TB, Her E, Kim SH, Kim K, Azuma I, Kim JB.
    Int Immunopharmacol; 2001 May 19; 1(5):881-9. PubMed ID: 11379043
    [Abstract] [Full Text] [Related]

  • 20. [Ingredients of mistletoe (Viscum album L.) as potential drugs].
    Franz H.
    Pharmazie; 1985 Feb 19; 40(2):97-104. PubMed ID: 3889937
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.